• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Epigraph hemagglutinin vaccine induces broad cross-reactive immunity against swine H3 influenza virus

tetano

Editor, Senior Moderator
Nat Commun


. 2021 Feb 22;12(1):1203.
doi: 10.1038/s41467-021-21508-6.
Epigraph hemagglutinin vaccine induces broad cross-reactive immunity against swine H3 influenza virus


Brianna L Bullard[SUP] 1 [/SUP], Brigette N Corder[SUP] 1 [/SUP], Jennifer DeBeauchamp[SUP] 2 [/SUP], Adam Rubrum[SUP] 2 [/SUP], Bette Korber[SUP] 3 [/SUP], Richard J Webby[SUP] 2 [/SUP], Eric A Weaver[SUP] 4 [/SUP]



Affiliations

Abstract

Influenza A virus infection in swine impacts the agricultural industry in addition to its zoonotic potential. Here, we utilize epigraph, a computational algorithm, to design a universal swine H3 influenza vaccine. The epigraph hemagglutinin proteins are delivered using an Adenovirus type 5 vector and are compared to a wild type hemagglutinin and the commercial inactivated vaccine, FluSure. In mice, epigraph vaccination leads to significant cross-reactive antibody and T-cell responses against a diverse panel of swH3 isolates. Epigraph vaccination also reduces weight loss and lung viral titers in mice after challenge with three divergent swH3 viruses. Vaccination studies in swine, the target species for this vaccine, show stronger levels of cross-reactive antibodies and T-cell responses after immunization with the epigraph vaccine compared to the wild type and FluSure vaccines. In both murine and swine models, epigraph vaccination shows superior cross-reactive immunity that should be further investigated as a universal swH3 vaccine.
 
Back
Top Bottom